248 related articles for article (PubMed ID: 30342956)
1. An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications.
Maccari R; Del Corso A; Paoli P; Adornato I; Lori G; Balestri F; Cappiello M; Naß A; Wolber G; Ottanà R
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3712-3720. PubMed ID: 30342956
[TBL] [Abstract][Full Text] [Related]
2. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B.
Ottanà R; Paoli P; Cappiello M; Nguyen TN; Adornato I; Del Corso A; Genovese M; Nesi I; Moschini R; Naß A; Wolber G; Maccari R
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435264
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents.
Maccari R; Vitale RM; Ottanà R; Rocchiccioli M; Marrazzo A; Cardile V; Graziano AC; Amodeo P; Mura U; Del Corso A
Eur J Med Chem; 2014 Jun; 81():1-14. PubMed ID: 24819954
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
Kousaxidis A; Petrou A; Lavrentaki V; Fesatidou M; Nicolaou I; Geronikaki A
Eur J Med Chem; 2020 Dec; 207():112742. PubMed ID: 32871344
[TBL] [Abstract][Full Text] [Related]
6. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
[TBL] [Abstract][Full Text] [Related]
7. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
8. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
9. Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.
Genovese M; Imperatore C; Casertano M; Aiello A; Balestri F; Piazza L; Menna M; Del Corso A; Paoli P
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677434
[TBL] [Abstract][Full Text] [Related]
10. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
[TBL] [Abstract][Full Text] [Related]
11. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
[TBL] [Abstract][Full Text] [Related]
12. Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors.
Maccari R; Wolber G; Genovese M; Sardelli G; Talagayev V; Balestri F; Luti S; Santi A; Moschini R; Del Corso A; Paoli P; Ottanà R
Eur J Med Chem; 2023 Apr; 252():115270. PubMed ID: 36934484
[TBL] [Abstract][Full Text] [Related]
13. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activity of Aralia continentalis roots on protein tyrosine phosphatase 1B and rat lens aldose reductase.
Jung HJ; Jung HA; Kang SS; Lee JH; Cho YS; Moon KH; Choi JS
Arch Pharm Res; 2012 Oct; 35(10):1771-7. PubMed ID: 23139128
[TBL] [Abstract][Full Text] [Related]
16. Small molecules as potent protein tyrosine phosphatase 1B (PTP1B) inhibitors documented in patents from 2009 to 2013.
Wang LJ; Jiang B; Wu N; Wang SY; Shi DY
Mini Rev Med Chem; 2015; 15(2):104-22. PubMed ID: 25643610
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
18. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel PTP1B inhibitors with antihyperglycemic activity.
Liu Z; Chai Q; Li YY; Shen Q; Ma LP; Zhang LN; Wang X; Sheng L; Li JY; Li J; Shen JK
Acta Pharmacol Sin; 2010 Aug; 31(8):1005-12. PubMed ID: 20686525
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
